91 related articles for article (PubMed ID: 17213022)
1. Chromosomal changes associated with clinical outcome in lymph node-negative breast cancer.
Karlsson E; Danielsson A; Delle U; Olsson B; Karlsson P; Helou K
Cancer Genet Cytogenet; 2007 Jan; 172(2):139-46. PubMed ID: 17213022
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors.
Hermsen MA; Baak JP; Meijer GA; Weiss JM; Walboomers JW; Snijders PJ; van Diest PJ
J Pathol; 1998 Dec; 186(4):356-62. PubMed ID: 10209483
[TBL] [Abstract][Full Text] [Related]
3. High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.
Möllerström E; Delle U; Danielsson A; Parris T; Olsson B; Karlsson P; Helou K
Cancer Genet Cytogenet; 2010 Apr; 198(2):79-89. PubMed ID: 20362222
[TBL] [Abstract][Full Text] [Related]
4. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
[TBL] [Abstract][Full Text] [Related]
5. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
Rennstam K; Ahlstedt-Soini M; Baldetorp B; Bendahl PO; Borg A; Karhu R; Tanner M; Tirkkonen M; Isola J
Cancer Res; 2003 Dec; 63(24):8861-8. PubMed ID: 14695203
[TBL] [Abstract][Full Text] [Related]
6. Chromosome alterations associated with positive and negative lymph node involvement in breast cancer.
Wuicik L; Cavalli LR; Cornélio DA; Schmid Braz AT; Barbosa ML; Lima RS; Urban CA; Bleggi Torres LF; Ribeiro EM; Cavalli IJ
Cancer Genet Cytogenet; 2007 Mar; 173(2):114-21. PubMed ID: 17321326
[TBL] [Abstract][Full Text] [Related]
7. The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer.
Becker TE; Ellsworth RE; Deyarmin B; Patney HL; Jordan RM; Hooke JA; Shriver CD; Ellsworth DL
Ann Surg Oncol; 2008 Apr; 15(4):1056-63. PubMed ID: 18246400
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
9. Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes.
Ellsworth RE; Ellsworth DL; Neatrour DM; Deyarmin B; Lubert SM; Sarachine MJ; Brown P; Hooke JA; Shriver CD
Mol Cancer Res; 2005 Feb; 3(2):71-7. PubMed ID: 15755873
[TBL] [Abstract][Full Text] [Related]
10. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
[TBL] [Abstract][Full Text] [Related]
11. The accumulation of multiple genetic abnormalities in individual tumor cells in human breast cancers: clinical prognostic implications.
Shackney SE; Pollice AA; Smith CA; Alston L; Singh SG; Janocko LE; Brown KA; Petruolo S; Groft DW; Yakulis R; Hartsock RJ
Cancer J Sci Am; 1996; 2(2):106-13. PubMed ID: 9166508
[TBL] [Abstract][Full Text] [Related]
12. Patterns of DNA copy number changes in sentinel lymph node breast cancer metastases.
Santos SC; Cavalli IJ; Ribeiro EM; Urban CA; Lima RS; Bleggi-Torres LF; Rone JD; Haddad BR; Cavalli LR
Cytogenet Genome Res; 2008; 122(1):16-21. PubMed ID: 18931481
[TBL] [Abstract][Full Text] [Related]
13. The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.
Bachmann HS; Otterbach F; Callies R; Nückel H; Bau M; Schmid KW; Siffert W; Kimmig R
Clin Cancer Res; 2007 Oct; 13(19):5790-7. PubMed ID: 17908970
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
[TBL] [Abstract][Full Text] [Related]
15. Genomic alterations associated with early stages of breast tumor metastasis.
Ellsworth RE; Ellsworth DL; Patney HL; Deyarmin B; Hooke JA; Love B; Shriver CD
Ann Surg Oncol; 2008 Jul; 15(7):1989-95. PubMed ID: 18401664
[TBL] [Abstract][Full Text] [Related]
16. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.
Isola JJ; Kallioniemi OP; Chu LW; Fuqua SA; Hilsenbeck SG; Osborne CK; Waldman FM
Am J Pathol; 1995 Oct; 147(4):905-11. PubMed ID: 7573366
[TBL] [Abstract][Full Text] [Related]
17. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
20. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
